The Board of Directors of Synmosa Biopharma Corporation has authorized a buyback plan on March 29, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.05 TWD | +0.25% | +0.75% | +3.62% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.62% | 473M | |
+42.27% | 748B | |
+33.99% | 598B | |
-5.93% | 356B | |
+18.36% | 325B | |
+4.79% | 283B | |
+17.40% | 245B | |
+9.07% | 211B | |
-4.34% | 209B | |
+2.69% | 166B |
- Stock Market
- Equities
- 4114 Stock
- News Synmosa Biopharma Corporation
- Synmosa Biopharma Corporation authorizes a Buyback Plan.